Is smokeless tobacco use an appropriate public health strategy for reducing societal harm from cigarette smoking?

International Journal of Environmental Research and Public Health

Volumn 6, Issue 1, 2009, Pages 10-24

  Tomar, Scott L ^a   Fox, Brion J ^b   Severson, Herbert H ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c OREGON RESEARCH INSTITUTE   (United States)

Author keywords

Harm reduction; Smokeless tobacco; Smoking cessation; Smoking initiation

Indexed keywords

NICOTIANA TABACUM;

EID: 61449129668     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6010010     Document Type: Review

References (90)

1. Gartner, C.E.; Hall, W.D.; Vos, T.; Bertram, M.Y.; Wallace A.K.; Lim, S.S. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modeling study. Lancet 2007, 369, 2010-2014.
2. Stratton, K.; Shetty, P.; Wallace, R.; Bondurant, S. Clearing the Smoke: Assessing the science base for tobacco harm reduction. National Academy Press: Washington, D.C., U.S., 2001.
3. Royal College of Physicians of London. Harm reduction in nicotine addiction: helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians. Royal College of Physicians of London: London, UK, 2007. Available at: http://www.rcplondon.ac.uk/pubs/contents/ 4fc74817-64c5-4105-951e-38239b09c5db.pdf
4. Rodu, B.; Godshall, W.T. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct. J. 2006, 3, 37.
5. Kozlowski, L.T.; O'Connor, R.J.; Edwards, B.Q. Some practical points on harm reduction: what to tell your lawmaker and what to tell your brother about Swedish snus. Tob. Control. 2003, 12, 372-373.
6. st century. American Council on Science and Health; New York, U.S., 2003.
7. Brinson, B. Relative benefits: smokeless tobacco is thought to present less of a health risk than cigarettes; but many health advocates remain unconvinced. Tob. Reporter 2006, March, 30-32.
8. Bates, C.; Fagerstrom, K.; Jarvis, M.J.; Kunze, M.; McNeill, A.; Ramstrom, L. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health. Tob. Control. 2003, 12, 360-367.
9. Nelson, D.E.; Mowery, P.; Tomar, S.; Marcus, S.; Giovino, G.; Zhao, L. Trends in smokeless tobacco use among adults and adolescents in the United States. Am. J. Public Health 2006, 96, 897-905.
10. Federal Trade Commission. Smokeless tobacco report for the years 2002-2005. Federal Trade Commission: Washington, D.C., U.S., 2007. Available at http://www.ftc.gov/reports/tobacco/02-05smokeless0623105.pdf
11. Statistics Sweden. Use of alcohol and tobacco. Official Statistics of Sweden. Living Conditions Report No. 114. Statistics Sweden, Unit of Social Welfare: Stockholm, Sweden, 2007.
12. Braverman, M.T.; Svendsen, T.; Lund, K.E.; Aaro, L.E. Tobacco use by early adolescents in Norway. Eur. J. Public Health 2001, 11, 218-224.
13. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Rockville, MD., U.S., 2007. DHHS Publication No. SMA 07-4293.
14. Hatsukami, D.K.; Lemmonds, C.; Tomar, S.L. Smokeless tobacco use: harm reduction or induction approach? Prev. Med. 2003, 38, 309-317.
15. Hatsukami, D.K.; Henningfield, J.E.; Kotlyar, M. Harm reduction approaches to reducing tobacco-related mortality. Annu. Rev. Public Health 2004, 25, 377-395.
16. Critchley, J.A.; Unal, B. Health effects associated with smokeless tobacco: a systematic review. Thorax. 2003, 58, 435-443.
17. Savitz, D.A.; Meyer, R.E.; Tanzer, J.M.; Mirvish, S.S.; Lewin, F. Public health implications of smokeless tobacco use as a harm reduction strategy. Am. J. Public Health 2006, 11, 1934-1939.
18. Tomar, S. Is smokeless tobacco effective in reducing cigarette smoking and tobacco-related harms? Member commentary on the smokeless tobacco debate. Soc. Res. Nicotine Tob. Newsletter 2005, 11, 2-3.
19. Luo, J.; Ye, W.; Zendehdel, K.; Adami, J.; Adami, H.O.; Boffetta, P.; Nyrén, O. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction works: a retrospective cohort study. Lancet 2007, 369, 2015-2020.
20. Boffetta, P.; Aagnes, B.; Weiderpass, E.; Andersen, A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int. J. Cancer 2005, 114, 992-995.
21. Alguacil, J.; Silverman, D.T. Smokeless and other noncigarette tobacco use and pancreatic cancer: a case-control study based on direct interviews. Cancer Epidemiol. Biomarker. Prev. 2004, 13, 55-58.
22. International Agency for Research on Cancer. Tobacco habits other than smoking. IARC Monog. Eval. Carcinog. Risk Chem. Hum. Vol. 37. International Agency for Research on Cancer: Lyon, France, 1985.
23. International Agency for Research on Cancer. Smokeless tobacco and some tobacco-related N-nitrosamines. IARC Monog. Eval. Carcinog. Risk Chem. Hum. Vol. 89. International Agency for Research on Cancer: Lyon, France, 2007.
24. U.S. Department of Health and Human Services The health consequences of using smokeless tobacco. A report of the Advisory Committee to the Surgeon General. U.S. Department of Health and Human Services, Public Health Service: Bethesda, MD, U.S., 1986. NIH Publication No. 86-2874.
25. th Ed.; Department of Health and Human Services, Public Health Service, National Toxicology Program: Research Triangle Park, N.C., U.S., 2005.
26. Levy, D.T.; Mumford, E.A.; Cummings, K.M.; Gilpin, E.A.; Giovino, G.; Hyland, A.; Sweanor, D.; Warner, K.E. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol. Biomarker. Prev. 2004, 13, 2035-2042.
27. Richter, P.; Hodge, K.; Stanfill, S.; Zhang, L.; Watson, C. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines. Nicotine Tob. Res. 2008, 10, 1645-1652.
28. Stepanov, I.; Jensen, J.; Hatsukami, D.; Hecht, S.S. New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels. Nicotine Tob. Res. 2008, 10, 1773-1782.
29. Royal College of Physicians of London. Protecting smokers, saving lives: the case for a tobacco and nicotine regulatory authority. Royal College of Physicians of London: London, U.K., 2002. Available at http://www.rcplondon.ac.uk/pubs/books/protsmokers/index.asp.
30. Reynolds American Inc. Reynolds American CEO: 'Progress Continues, Profits Climb' [press release]. 27 April 2006. Available at http://www. reynoldsamerican.com/Newsroom/.%5Ccommon% 5CViewPDF.aspx?postID=1128. Accessed on 13 March 2007.
31. Altria Group, Inc. Remarks by Michael E. Szymanczyk, Chairman and CEO, Philip Morris USA Inc. at Prudential Consumer Conference. Boston, U.S., September 7, 2006. http://www.altria.com/media/press-release/03-02-pr-2006-09- 07-01.asp. Accessed on March 13, 2007.
32. Philip Morris USA. Marlboro Snus fact sheet. Available at http://www.philipmorrisusa.com/en/popup-marlboro-snus-fact-sheet.asp?source= home? Accessed on June 25, 2007.
33. U.S. Smokeless Tobacco Company. Magazine advertisement for Skoal® moist snuff: "Enjoy tobacco on a 4-hour flight? Absolutely." 2005. Available at http://www.trinketsandtrash.org/tearsheet.asp?ItemNum=210630. Accessed on March 13, 2007.
34. U.S. Smokeless Tobacco Company. Magazine advertisement for Skoal® moist snuff:"Enjoy tobacco in a smoke-free sports bar? Believe it." 2005. Available at http://www.trinketsandtrash.org/tearsheet.asp?ItemNum=210555. Accessed on March 13, 2007.
35. Luik, J.C. The truth that dare not speak: the moral case for smokeless tobacco. Tob. Report. 2006, March, 22-28.
36. Bolinder, G.; Alfredssom, L.; Englund, A.; deFaire, U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am. J. Public Health 1994, 84, 399-404.
37. Henley, S.J.; Connell, C.J.; Richter, P.; Husten, C.; Pechacek, T.; Calle, E.E.; Thun, M.J. Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco. Tob. Control 2007, 16, 22-28.
38. Rodu, B.; Stier, J. Smokeout: not as easy as ABC. The Washington Times, November 13, 2005. p. B03.
39. LaVecchia, C.; Lucchini, F.; Negri, E.; Boyle, P.; Maisoneuve, P.; Levi F. Trends of cancer mortality in Europe, 1985-1989: II and IV. Eur. J. Cancer 1992, 28, 514-599; 28A, 1210-1281.
40. Peto, R.; Lopez, A.D.; Boreham, J.; Thun, M.J.; Health, C. Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 2006, 339, 1268-1278.
41. U.S. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, Georgia, 2004.
42. Kozlowski, L.T. Harm reduction, public health, and human rights: smokers have a right to be informed of significant harm reduction options. Nicotine Tob. Res. 2002, 4, S55-S60.
43. Phillips, C.V.; Guenzel, B.; Bergen, P. Deconstructing anti-harm reduction metaphors: mortality risk from falls and other traumatic injuries compared to smokeless tobacco use. Harm Reduct. J. 2005, 3, 15.
44. Weinstein, N.D.; Marcus, S.E.; Moser, R.P. Smokers' unrealistic optimism about their risk. Tob. Control 2005, 14, 55-59.
45. Petty, R.E.; Cacioppo, J.T. Communication and persuasion: central and peripheral routes to attitude change. Springer-Verlag: New York, U.S., 1986.
46. Slovic, P. Smoking: Risk, Perception and Policy. Sage, Thousand Oaks, CA, U.S., 2001.
47. Tomar, S.L. Association between smoking and snuff use in U.S. men: implications for harm reduction. Am. J. Prev. Med. 2002, 23, 143-149.
48. Bombard, J.M.; Pederson, L.L.; Nelson, D.E.; Malarcher, A.M. Are smokers only using cigarettes: exploring current polytobacco use among an adult population. Addict. Behav. 2007, 32, 2411-2419.
49. Foulds, J., Ramstrom, L., Burke, M., Fagerstrom, K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob. Control 2003, 12, 349-359.
50. Furberg, H.; Bulik, C.M.; Lerman, C.; Lichtenstein, P.; Pederson, N.L.; Sullivan, P.F. Is Swedish snus associated with smoking initiation or smoking cessation. Tob. Control 2005, 14, 422-424.
51. Ramstrom, L.M.; Foulds, J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob. Control 2006, 15, 210-214.
52. Tomar, S.L. Epidemiological perspectives on smokeless tobacco marketing and population harm. Am. J. Prev. Med. 2007, 33, S387-S397.
53. Novotny, T.E.; Pierce, J.P.; Fiore, M.C.; Davis, R.M. Smokeless tobacco use in the United States: the adult use of tobacco surveys. NCI Monogr. 1989, 8, 25-28.
54. Kozlowski, L.T.; O'Connor, R.J.; Edwards, B.Q.; Flaherty, B.P. Most smokeless tobacco use is not a causal gateway to cigarettes: using order of product use to evaluate causation in a national U.S. sample. Addiction 2003, 98, 1077-1085.
55. Tomar, S.L.; Loree, M. Errors in analyzing associations between use of smokeless tobacco and cigarettes. Addiction 2004, 99, 260-262.
56. Tilashalski, K.; Rodu, B.; Cole, P. A pilot study of smokeless tobacco in smoking cessation. Am. J. Med. 1998, 104, 456-458.
57. Tilashalski, K.; Rodu, B.; Cole, P. Seven year follow-up of smoking cessation with smokeless tobacco. J. Psychoactive Drugs 2005, 37, 105-108.
58. Tønnesen, P.; Mikkelsen, K.; Bremann, L. Smoking cessation with smokeless tobacco and group therapy: an open, randomized, controlled trial. Nicotine Tob. Res. 2008, 10, 1365-1372.
59. Fiore, M.C.; Bailey, W.C.; Cohen, S.J.; et al. Treating tobacco use and dependence. U.S. Department of Health and Human Services, Public Health Service: Rockville, MD., U.S., 2000.
60. Office of National Drug Control Policy. Methadone [fact sheet]. White House, Office of National Drug Control Policy, Drug Policy Information Clearinghouse: Rockville, MD., U.S., 2000. Available at www. whitehousedrugpolicy.gov/publications/factsht/methadone/index.html. Accessed on 20 November 2007.
61. Djordjevic, M.V.; Hoffmann, D.; Glynn, T.; Connolly, G.N. US commercial brands of moist snuff, 1994. I. Assessment of nicotine, moisture, and pH. Tob. Control 1995, 4, 62-66.
62. Henningfield, J.; Radzius, A.; Cone, E. Estimation of available nicotine content in six smokeless tobacco products. Tob. Control 1995, 4, 57-61.
63. Henningfield, J.E.; Rose, C.A.; Giovino, G.A. Brave new world of tobacco disease prevention: promoting dual tobacco-product use? Am. J. Prev. Med. 2002, 23, 226-228.
64. Johnston, L.D.; O'Malley, P.M.; Bachman, J.G.; Schulenber, J.E. Monitoring the Future: national results on adolescent drug use. Overview of key findings, 2006. U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse: Bethesda, MD, U.S., 2007. NIH Publication No. 07-6202.
65. Ary, D.V.; Lichtenstein, E.; Severson, H.H. Smokeless tobacco use among male adolescents: patterns, correlates predictors and the use of other drugs. Prev. Med. 1987, 16, 385-401.
66. Ary, D.V. Use of smokeless tobacco among male adolescents: concurrent and prospective relationships. NCI Monogr. 1989, 8, 49-55.
67. Dent, C.W.; Sussman, S.; Johnson, C.A.; Hansen, W.B.; Flay, B.R. Adolescent smokeless tobacco incidence: relationship with other drugs and psychosocial variables. Prev. Med. 1987, 16, 422-431.
68. Glover, E.D.; Laflin, M.; Edwards, S.W. Age of initiation and switching patterns between smokeless tobacco and cigarettes among college students in the United States. Am. J. Public Health 1989, 79, 207-208.
69. Tomar, S.L. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob. Res. 2003, 5, 561-569.
70. O'Connor, R.J.; Flaherty, B.P.; Quinio Edwards, B.; Kozlowski, L.T. Regular smokeless tobacco use is not a reliable predictor of smoking onset when psychosocial predictors are included in the model. Nicotine Tob. Res. 2003, 5, 535-543.
71. Tomar, S.L. Smokeless tobacco use is a significant predictor of smoking when appropriately modeled. Nicotine Tob. Res. 2003, 5, 571-573.
72. Severson, H.H.; Forrester, K.K.; Biglan, A. Use of smokeless tobacco is a risk factor for cigarette smoking. Nicotine Tob Res. 2007, 9, 1131-1137.
73. Haddock, C.K.; Vander Weg, M.; DeBon, M.; Klesges, R.C.; Talcott, G.W.; Lando, H.; Peterson, A. Evidence that smokeless tobacco use is a gateway for smoking initiation in young adult males. Prev. Med. 2001, 32, 262-267.
74. Myers, M. Statement of Matthew Myers, President, Campaign for Tobacco-Free Kids, on Smokeless (Spit) Tobacco Before the U.S. House Energy and Commerce Committee, Subcommittee on Commerce, Trade and Consumer Protection, June 3, 2003. Available at http://tobaccofreekids.org/reports/spit/ MyersTestimony.pdf. Accessed on April 24, 2007.
75. Campaign for Tobacco Free Kids. A Broken Promise to our Children. The 1998 State Tobacco Settlement Eight Years Later. Campaign for Tobacco Free Kids: Washington, D.C., U.S., 2006. Available at: http://tobaccofreekids.org/ reports/settlements/2007/fullreport.pdf. Accessed on April 24, 2007.
76. Gartner, C.E.; Hall, W.D.; Chapman, S.; Freeman, B. Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med. 2007, 4, 1703-1704.
77. Antonsson, A.B. Substitution of dangerous chemicals - the solution to problems with chemical hazards in the work environment? Am. Ind. Hyg. Assoc. J. 1995, 56, 394-397.
78. Fischer, K., Schot, J., Eds. Environmental strategies for industry: international perspectives on research needs and implications. Island Press: Washington, D.C., U.S., 1993.
79. Rothman, A.J.; Kiviniemi, M.T. Treating people with information: an analysis and review of approaches to communicating health risk information. J. Natl. Cancer Inst. Monogr. 1999, 25, 44-51.
80. National Cancer Institute. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and Tobacco Control Monographs No. 13. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute: Bethesda, MD, U.S., 2001. NIH Pub. No 02-5074.
81. Kahneman, D., Tversky, A., Slovic, P., Eds. Judgment under uncertainty: heuristics and biases. Cambridge University Press: New York, U.S., 1982.
82. Remington, P.L. Communicating public health information effectively: a guide for practitioners. Nelson, D.E., Parvanta, C., Eds.; American Public Health Association: Washington, DC, U.S., 2002.
83. United States District Court for The District of Columbia. United States of America et al. v. Philip Morris USA, Inc., et al. Civil Action No. 99-2496 (GK). Final Opinion. United States District Court for The District of Columbia: Washington, DC, U.S., 1999. Available at: http://tobaccofreekids. org/reports/doj/FinalOpinion.pdf. Accessed on June 25, 2007.
84. Ling, P.M.; Glantz, S.A. Tobacco industry consumer research on socially acceptable cigarettes. Tob. Control 2005, 14, 1-16.
85. Barnoya, J.; Glantz, S.A. The tobacco industry's worldwide ETS consultants project: European and Asian components. Eur. J. Public Health 2006, 16, 69-77.
86. Bero, L.A. Tobacco industry manipulation of research. Public Health Rep. 2005, 120, 200-208.
87. Parascandola, M. Science, industry, and tobacco harm reduction: a case study of tobacco industry scientists' involvement in the National Cancer Institute's Smoking and Health Program, 1964-1980. Public Health Rep. 2005, 120, 338-349.
88. Muggli, M.E.; Forster, J.L.; Hurt, R.D.; Repace, J.L. The smoke you don't see: uncovering tobacco industry scientific strategies aimed against environmental tobacco smoke policies. Am. J. Public Health 2001, 91, 1419-1423.
89. McDaniel, P.A.; Smith, E.A.; Malone, R.E. Philip Morris's Project Sunrise: weakening tobacco control by working with it. Tob. Control 2006, 15, 215-223.
90. Cranor, C.F. Toward understanding aspects of the precautionary principle. J. Med. Philos. 2004, 29, 259-279.